Furthermore, in vivo investigations on a melanoma nude mice model indicated that injection of TRAIL-exosome-TP intravenously suppresses tumor progression capabilities, implying the promising potential of this delivery system in the treatment of malignant melanoma (Jiang et al., 2021). Here, TNFSF10 is linked to neoplasm.